• 1: Home
• 2: MPS Diseases
  • 2.1: Overview of symptoms
  • 2.2: Overview of treatment
  • 2.3: Which are the MPS Diseases
    • 2.3.1: MPS I
    • 2.3.2: MPS II
    • 2.3.3: MPS III
    • 2.3.4: MPS IVA
    • 2.3.5: MPS VI
    • 2.3.6: MPS VII
    • 2.3.7: ML I
    • 2.3.8: ML II and III
    • 2.3.9: ML IV
    • 2.3.10: Fucosidosis
    • 2.3.11: Mannosidosis
    • 2.3.12: Sialic Acid Storage Disease
    • 2.3.13: MSD
    • 2.3.14: AGU
    • 2.3.15: Winchester
  • 2.4: Personal stories
• 3: Fabry Disease
• 4: Advocacy Support
• 6: Fundraising
• 7: How Your Money Helps
• 8: Research
• 9: Information Resource
• 10: Kids Section
• 11: Events
• 12: Childhood Wood
• 13: Latest News
• 14: Downloads
• 15: Contact Us
• 16: Register a Sufferer
• 17: Become a Friend of MPS
• 18: LSD Collaborative
• 19: International Contacts
• 22: MPS House
• 27: CRB Checks
• 28: Links
• 29: Site Map
• 30: Terms and Conditions

These rare lysosomal storage diseases are refered to as MPS I-VII or more commonly by the name of the doctor who first described the condition. These commonly include:

MPS I - Hurler, Hurler Scheie and Scheie
MPS II - Hunter
MPS III - Sanfiippo
MPS IVA - Morquio
MPS IVB - GM-1 Gangliosidosis
MPS VI - Maroteaux-Lamy
MPS VII - Sly
MPS IX - Natowicz

Included also are the Mucolipidoses, other 'storage diseases' and the following conditions which are similar to Mucopolysaccharide Diseases:

ML I - Neuramidase Deficiency
ML II -  I-Cell Disease
ML III - Pseudo Hurler Polydystrophy
ML IV
Fucosidosis
Mannosidosis
Sialic Acid Disease
Multiple Sulfatase Deficiency
Aspartylglycosaminuria
Winchester Syndrome
Geleo Physic Dysplasia
Fabry Disease

 

Overview of symptoms

Overview of treatment

Personal stories